FITC anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody

Pricing & Availability
Clone
RB6-8C5 (See other available formats)
Regulatory Status
RUO
Other Names
Gr-1
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
rb6-8c5
C57BL/6 mouse bone marrow stained with Ly-6G/Ly-6C (clone RB6-8C5) FITC and CD11b PE.
  • rb6-8c5
    C57BL/6 mouse bone marrow stained with Ly-6G/Ly-6C (clone RB6-8C5) FITC and CD11b PE.
See FITC spectral data
Cat # Size Price Quantity Avail. Save
108405 50 µg £14.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108406 500 µg £79.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Gr-1 is a 21-25 kD protein also known as Ly-6G/Ly-6C. This myeloid differentiation antigen is a glycosylphosphatidylinositol (GPI)-linked protein expressed on granulocytes and macrophages. In bone marrow, the expression levels of Gr-1 directly correlate with granulocyte differentiation and maturation; Gr-1 is also transiently expressed on bone marrow cells in the monocyte lineage. Immature Myeloid Gr-1+ cells play a role in the development of antitumor immunity.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Raised against granulocytes of mouse origin
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C19. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A819. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.420.

The RB6-8C5 antibody has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. Additional reported applications (for relevant formats of this clone) include: in vitro complement-mediated cytotoxicity2, in vivo depletion3-5,9, immunoprecipitation1, immunohistochemical staining6 (including paraffin-embedded sections9,16,33-35, acetone-fixed frozen sections11 and zinc-fixed sections15), and Western blotting7. RB6-8C5 is not suitable for depletion of hepatic myeloid derived suppressor cells (MDSCs)20.

Special Note: For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 108436).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (IP)
  2. Brummer E, et al. 1984. J. Leukocyte Biol. 36:505. (CMCD)
  3. Stoppacciaro A, et al. 1993. J. Exp. Med. 178:151. (Deplete)
  4. Tumpey TM, et al. 1996. J. Virol. 70:898. (Deplete)
  5. Czuprynski CJ, et al. 1994. J. Immunol. 152:1836. (Deplete)
  6. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  7. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (WB)
  8. Engwerda CR, et al. 2004. Am. J. Pathol. 165:2123.
  9. Brown CR, et al. 2004. Infect. Immun. 72:4956. (Deplete, IHC)
  10. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) PubMed
  11. Li M, et al. 2006. P. Natl. Acad. Sci USA 103:11736. (IHC)
  12. Dzhagalov I, et al. 2007. Blood 109:1620. (FC) PubMed
  13. Fazilleau N, et al. 2007. Nature Immunol. 8:753. (FC) PubMed
  14. Heuser M, et al. 2007. Blood 110:1639. (FC) PubMed
  15. Wang T, et al. 2007. Infect. Immun. 75:1144. (IHC)
  16. Bosio CM, et al. 2007. J. Immunol. 178:4538. (IHC)
  17. Boehme SA, et al. 2009. Int. Immunol. 21:81. (IHC)
  18. Piao Y, et al. 2012. Neuro Oncol. 14:1379. PubMed
  19. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  20. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  21. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  22. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  23. Korrer MJ, et al. 2014. PLoS One. 9:91370. PubMed
  24. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  25. Collins C, et al. 2014. PNAS. 111:9899. PubMed
  26. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  27. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  28. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  29. Roderick JE, et al. 2014. PNAS. 111:14436. PubMed
  30. Distel E, et al. 2014. Circ Res. 115:759. PubMed
  31. Iwai H, et al. 2015. Tuberculosis. 95:246. PubMed
  32. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
  33. Whiteland J, et al. 1994 J Histochem Cytochem 43:3 (IHC-P)
  34. Brown C, et al. 2003 J Immunology 171:2 (IHC-P)
  35. Obregon-Henao A, et al. PLoS One 8:11 (IHC-P)
Product Citations
  1. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  2. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  3. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  4. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  5. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  6. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  7. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  8. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  9. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  10. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  11. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  12. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  13. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
  14. Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
  15. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  16. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  17. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  18. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  19. Fang R, et al. 2019. Mucosal Immunol. 12:1092. PubMed
  20. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  21. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  22. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  23. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  24. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  25. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  26. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  27. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  28. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  29. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  30. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  31. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  32. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  33. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  34. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  35. Piao W, et al. 2020. Cell Reports. 30(4):1052-1062.e5.. PubMed
  36. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  37. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  38. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  39. Karachi A, et al. 2019. Neuro Oncol. 1.381944444. PubMed
  40. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  41. Cuff AO, et al. 2020. Frontiers in Immunology. 1.930555556. PubMed
  42. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  43. DiMenna L, et al. 2010. J Immunol. 184:5475. PubMed
  44. Morimura S, et al. 2013. Am J Pathol. 182:6140. PubMed
  45. Morales J, et al. 2014. J Leukoc Biol. 95:643. PubMed
  46. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  47. Chauhan P, et al. 2014. Int Immunopharmacol. 21:63. PubMed
  48. Yamada D, et al. 2014. J Immunol. 192:4112. PubMed
  49. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  50. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  51. Suo J, et al. 2014. J Leukoc Biol. 96:133. PubMed
  52. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  53. Blijswijk J, et al. 2015. J Immunol. 194:307. PubMed
  54. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  55. Kitur K, et al. 2015. PLoS Pathog. 11:1004820. PubMed
  56. An J, et al. 2015. Biochem Biophys Res Commun. 461:142. PubMed
  57. Zhang J, et al. 2015. PLoS One. 10:130441. PubMed
  58. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  59. Ish-Shalom E, et al. 2016. J Immunol. 196: 156 - 167. PubMed
  60. Shankar J 2016. Innate Immunity. 22: 31 - 39. PubMed
  61. Chen Z, et al. 2016. PLoS One. 11: 0146681. PubMed
  62. Montagner S, et al. 2016. Cell Rep. 15: 1566-1579. PubMed
  63. Kitur K, et al. 2016. Cell Rep. 16:2219-2230. PubMed
  64. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  65. Maicas N, et al. 2017. PLoS One. 12(2):e0168981. PubMed
  66. Guan F, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0446-7. PubMed
  67. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  68. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  69. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  70. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  71. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  72. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  73. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  74. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  75. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  76. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  77. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  78. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  79. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
RRID
AB_313370 (BioLegend Cat. No. 108405)
AB_313371 (BioLegend Cat. No. 108406)

Antigen Details

Structure
21-25 kD
Distribution

Granulocytes, monocytes

Cell Type
Granulocytes, Monocytes, Neutrophils
Biology Area
Immunology, Innate Immunity
Antigen References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399.
2. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
3. Goni O, et al. 2002. Int. Immunol. 14:1125.

Gene ID
17067 View all products for this Gene ID 546644 View all products for this Gene ID
UniProt
View information about Ly-6G/Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12/09/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account